I love the throwback to Soylent. My ex-boyfriend in San Francisco used to eat that for every meal for a little while. It was very creepy. I think it's important for the business to have the solution. They can't avoid it. To pretend it's not happening is stupid from a CEO point of view. All these drug makers are making these drugs and they will be available to people. The question still remains personal accountability versus medical intervention.
WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventions? We ask our guest, WeightWatchers CEO Sima Sistani. Before and after the interview, Nayeema and Kara discuss their own experiences with diet fads and whether drugs like Wegovy and Ozempic will help America deal with the obesity epidemic or simply avoid tackling underlying issues like food supply, corporate greed and light regulation.
Questions? Comments? Email us at on@voxmedia.com or find us on Twitter @karaswisher and @nayeema
Learn more about your ad choices. Visit podcastchoices.com/adchoices